Beschreibung
CD147 plays important roles in variety of events including spermatogenesis, embryo implantation, neural network formation, is a member of the immunoglobulin superfamily. Recent studies have shown that the expression of CD147 is increased in many cancers, and it has been previously shown to be involved in cancer metastasis and progression. Therefore, CD147 and its antibody are used as an effective treatment for malignant tumors.
Specifications
Synonyms |
Basigin,BSG,5F7,CD147,EMMPRIN,M6,OK,TCSF |
Uniprot No. |
Q54A51 |
Source |
Recombinant Human CD147 Protein is expressed from HEK293 Cells with His tag at the C-terminal. It contains Ala 22 - His 205. |
Molecular Weight |
The protein has a predicted MW of 20.9 kDa. And it migrates as 25-33 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. |
Purity |
> 95% as determined by SDS-PAGE. |
Source |
<0.1 EU per 1μg of the protein by the LAL method. |
Formulation |
Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). |
Reconstitution |
Centrifuge tubes before opening.The concentration of protein solution used for lyophilization is generally 1mg/mL. Dissolve lyophilized protein with sterile water to ensure the concentration is greater than 100 μg/mL. |
Storage
The product should be stored at -25~-15℃ for 1 year from the date of receipt
2-7 days, 2 ~8 °C under sterile conditions after reconstitution.
3 months, -25~-15℃ under sterile conditions after reconstitution.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Note
1.Please operate with lab coats and disposable gloves for your safety.
2.This product is for research use only.
Product Data
Zahlung und Sicherheit
Ihre Zahlungsinformationen werden sicher verarbeitet. Wir speichern weder Kreditkartendaten noch Zugriff auf Ihre Kreditkarteninformationen.
Anfrage
Sie können auch mögen
FAQ
Das Produkt ist nur für Forschungszwecke bestimmt und nicht für die therapeutische oder diagnostische Anwendung bei Menschen oder Tieren. Produkte und Inhalte sind durch Patente, Marken und Urheberrechte von
Für bestimmte Anwendungen sind möglicherweise zusätzliche geistige Eigentumsrechte Dritter erforderlich.